US Map / North Carolina
State NC

Clinical Trials in North Carolina

Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.

Total Trials
359
Recruiting Now
359
← Back to US Map
Top Conditions in North Carolina
Cancer (8)Breast Cancer (7)Malignant Solid Neoplasm (6)Heart Failure (6)Obesity (5)Prostate Cancer (5)Atopic Dermatitis (5)Advanced Solid Tumor (4)Multiple Myeloma (4)Triple Negative Breast Cancer (4)Head and Neck Cancer (4)Colorectal Cancer (4)
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
View Trial →
NCT05063331 N/A
Recruiting
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
Condition
Uterine Prolapse
Enrollment
320 pts
Location
United States
Sponsor
University Hospitals Cleveland
View Trial →
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT03118986 Phase 2
Recruiting
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Che...
Condition
Vomiting in Infants and/or Children
Enrollment
200 pts
Location
United States, Canada, India
Sponsor
The Hospital for Sick Children
View Trial →
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT07159269 N/A
Recruiting
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advan...
Condition
Cardiovascular Disease Acute
Enrollment
75 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT07033169 N/A
Recruiting
A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
Condition
Dermatologic Disease
Enrollment
400 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy i...
Condition
Solid Tumor
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
View Trial →
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
View Trial →
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
View Trial →
NCT06590454 Phase 2
Recruiting
REVerse Intestinal Metaplasia in the Stomach (REVISE)
Condition
Gastric Intestinal Metaplasia
Enrollment
32 pts
Location
United States
Sponsor
Katherine Garman
View Trial →
NCT06066502 Phase 3
Recruiting
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
View Trial →
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.
View Trial →
NCT05912257 N/A
Recruiting
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizin...
Condition
Cancer
Enrollment
188 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06244212 N/A
Recruiting
Topical Treatment for Atopic Dermatitis
Condition
Atopic Dermatitis
Enrollment
30 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT06588556 N/A
Recruiting
Improving Needs Among Older Adults
Condition
Critical Illness
Enrollment
350 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT06621251 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosth...
Condition
Prosthetic Joint Infections of Hip
Enrollment
60 pts
Location
United States
Sponsor
Trellis Bioscience LLC
View Trial →
NCT05868629 N/A
Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In...
Condition
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06498128 N/A
Recruiting
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in P...
Condition
Insomnia
Enrollment
785 pts
Location
United States, Canada, France
Sponsor
Idorsia Pharmaceuticals Ltd.
View Trial →
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT05905328 Phase 1, Phase 2
Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Recei...
Condition
Cytokine Release Syndrome
Enrollment
54 pts
Location
United States
Sponsor
CytoAgents, Inc.
View Trial →
Page 5 of 15 — 359 trials total
← Prev Next →